Screener
Cocrystal Pharma COCP Q1 2026 Annual earnings
Reported May 15, 2026 · Before market open
Revenue$225.0KIn line
EPS-$0.17Miss by $0.02
Revenue estimate$225.0K
EPS estimate-$0.15
Next report
Nov 13, 2026 (in 2 months)Revenue estimate$105.0K
EPS estimate-$0.15
Versus estimates
Revenue
Q2 2026$105.0KIn line
Q1 2026$225.0KIn line
Diluted EPS
FAQ
- When did Cocrystal Pharma report Q1 2026 earnings?
- Cocrystal Pharma (COCP) reported Q1 2026 earnings on May 15, 2026 before market open.
- What were Cocrystal Pharma's Q1 2026 revenue and EPS?
- Cocrystal Pharma reported revenue of $225.0K and eps of $-0.17 for Q1 2026.
- Did Cocrystal Pharma beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $225.0K by -. EPS missed the consensus estimate of $-0.15 by $0.02.
- How did Cocrystal Pharma's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 26.1% from $-0.23.
- Where can I find Cocrystal Pharma's Q1 2026 SEC filings?
- You can read the 10-K periodic report (0001493152-26-013838) directly on SEC EDGAR. The filing index links above go to sec.gov.
